|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,165.00 GBX | +1.12% |
|
-1.50% | +18.66% |
| 02-13 | GSK : Receives a Buy rating from Jefferies | ZD |
| 02-13 | Bernstein, Barclays and Deutsche lower Relx | AN |
Chart calendar GSK plc
Upcoming events on GSK plc
| 19/02/2026 | For interim dividend | Add to your calendar Google Apple ICS format |
| 29/04/2026 | Q1 2026 Earnings Release | Add to your calendar Google Apple ICS format |
| 29/07/2026 | Q2 2026 Earnings Release | Add to your calendar Google Apple ICS format |
| 28/10/2026 | Q3 2026 Earnings Release | Add to your calendar Google Apple ICS format |
| 03/02/2027 | Q4 2026 Earnings Release | Add to your calendar Google Apple ICS format |
| 28/04/2027 | Q1 2027 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 28/07/2027 | Q2 2027 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 03/11/2027 | Q3 2027 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 02/02/2028 | Q4 2027 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
Past events on GSK plc
| 04/02/2026 | Q4 2025 Earnings Call |
| 04/02/2026 | Q4 2025 Earnings Release |
| 13/01/2026 | J.P. Morgan Healthcare Conference |
| 04/12/2025 | Citi Global Healthcare Conference |
| 03/12/2025 | Evercore Healthcare Conference |
| 19/11/2025 | Jefferies Global Healthcare Conference |
| 18/11/2025 | J.P. Morgan UK Leaders Conference |
| 13/11/2025 | For interim dividend |
| 12/11/2025 | UBS European Conference |
| 11/11/2025 | Guggenheim Healthcare Innovation Conference |
| 29/10/2025 | Q3 2025 Earnings Call |
| 29/10/2025 | Q3 2025 Earnings Release |
| 25/09/2025 | Bernstein Healthcare Forum |
| 24/09/2025 | Bank of America Global Healthcare Conference |
| 09/09/2025 | Morgan Stanley Global Healthcare Conference |
| 14/08/2025 | For interim dividend |
| 30/07/2025 | Q2 2025 Earnings Call |
| 30/07/2025 | Q2 2025 Earnings Release |
| 27/07/2025 | Alzheimer Association International Congress - Poster No:100775 |
| 27/07/2025 | Alzheimer Association International Congress - Poster No:103351 |
Past dividends on GSK plc
| 13/11/2025 | Interim Payment 0.16 GBP |
| 14/08/2025 | Interim Payment 0.16 GBP |
| 15/05/2025 | Interim Payment 0.16 GBP |
| 20/02/2025 | Final Payment 0.16 GBP |
| 14/11/2024 | Interim Payment 0.15 GBP |
| 15/08/2024 | Interim Payment 0.15 GBP |
| 16/05/2024 | Interim Payment 0.15 GBP |
| 22/02/2024 | Final Payment 0.16 GBP |
| 16/11/2023 | Interim Payment 0.14 GBP |
| 17/08/2023 | Interim Payment 0.14 GBP |
| 18/05/2023 | Interim Payment 0.14 GBP |
| 23/02/2023 | Final Payment 0.1375 GBP |
| 17/11/2022 | Interim Payment 0.1375 GBP |
| 18/08/2022 | Interim Payment 0.1625 GBP |
| 19/05/2022 | Interim Payment 0.14 GBP |
| 24/02/2022 | Final Payment 0.23 GBP |
| 18/11/2021 | Interim Payment 0.19 GBP |
| 19/08/2021 | Interim Payment 0.19 GBP |
| 20/05/2021 | Interim Payment 0.19 GBP |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 29 324 29 105 0.75% | 30 328 29 850 1.6% | 31 376 31 163 0.68% | 32 667 32 506 0.49% | 33 900 | 35 417 |
|
EBITDA Million GBP | Released Forecast Spread | 10 449 9 257 12.88% | 11 635 10 203 14.04% | 10 693 10 130 5.56% | 11 278 11 236 0.38% | 11 592 | 12 231 |
|
EBIT Million GBP | Released Forecast Spread | 8 151 7 952 2.5% | 8 786 8 780 0.07% | 9 148 9 011 1.52% | 9 783 9 649 1.39% | 10 182 | 10 960 |
|
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | 5 628 5 548 1.45% | 6 064 7 498 -19.12% | 3 477 4 752 -26.83% | 7 401 6 933 6.76% | 8 147 | 8 968 |
|
Net income Million GBP | Released Forecast Spread | 14 956 6 238 139.74% | 4 928 5 481 -10.09% | 2 575 3 509 -26.63% | 5 716 5 699 0.3% | 6 288 | 6 579 |
|
EPS GBP | Released Forecast Spread | 3,66 1,66 120.52% | 1,22 1,38 -11.61% | 0,63 0,85 -25.46% | 1,41 1,39 1.59% | 1,56 | 1,66 |
| Announcement Date | 01/02/23 | 31/01/24 | 05/02/25 | 04/02/26 |
Quarterly results
| Fiscal Period | September | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 S1 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 7 363 7 049 4.45% | 7 884 7 493 5.21% | 8 012 8 007 0.06% | 8 117 7 751 4.73% | 7 516 7 455 0.82% | 7 986 7 806 2.31% | 15 502 15 236 1.75% | 8 547 8 251 3.59% | 8 618 8 452 1.96% | 7 620 | 8 325 | 8 946 | 8 903 | 8 070 | 8 650 | 9 270 |
|
EBITDA Million GBP | Released Forecast Spread | 2 992 2 406 24.36% | 3 152 2 502 25.98% | 3 712 2 788 33.12% | 837 1 650 -49.29% | 3 356 2 603 28.94% | 3 790 2 700 40.37% | 3 723 2 958 25.86% | 409 1 769 -76.87% | 2 817 | 2 993 | 3 277 | 2 361 | ||||
|
EBIT Million GBP | Released Forecast Spread | 2 443 2 099 16.38% | 2 513 2 205 13.97% | 2 761 2 463 12.1% | 1 431 1 330 7.6% | 2 533 2 302 10.03% | 2 631 2 458 7.03% | 5 164 5 033 2.59% | 2 985 2 647 12.76% | 1 634 1 490 9.69% | 2 451 | 2 596 | 2 974 | 1 995 | 2 865 | 3 047 | 3 441 |
|
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | 1 355 1 696 -20.11% | 1 495 1 818 -17.77% | 64,0 2 023 -96.84% | 563 919 -38.74% | 2 108 | 2 456 2 396 2.5% | 950 | |||||||||
|
Net income Million GBP | Released Forecast Spread | 1 046 1 297 -19.32% | 1 173 1 386 -15.4% | -58,0 623 -109.31% | 414 750 -44.82% | 1 624 1 349 20.39% | 1 443 1 396 3.38% | 2 013 1 672 20.38% | 636 835 -23.84% | 1 488 | 1 612 | 1 845 | 1 066 | ||||
|
EPS GBP | Released Forecast Spread | 0,25 0,31 -19.17% | 0,29 0,34 -15.05% | -0,01 0,15 -109.28% | 0,10 0,18 -44.32% | 0,39 0,32 20.94% | 0,35 0,34 3.54% | 0,50 0,41 22% | 0,16 0,20 -22.5% | 0,37 | 0,40 | 0,45 | 0,26 | ||||
| Announcement Date | 01/05/24 | 31/07/24 | 30/10/24 | 05/02/25 | 30/04/25 | 30/07/25 | 30/07/25 | 29/10/25 | 04/02/26 | - | - | - | - | - | - | - |
| 18/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 18/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 19/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 19/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 19/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 20/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 20/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 20/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 20/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 23/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format |
Past sector events for GSK plc
| 13/02/2026 | Q3 2026 Earnings Release | |
| 13/02/2026 | Q3 2026 Earnings Release | |
| 13/02/2026 | Q3 2026 Earnings Release | |
| 13/02/2026 | Q3 2026 Earnings Release | |
| 13/02/2026 | Q3 2026 Earnings Release | |
| 13/02/2026 | Q3 2026 Earnings Release | |
| 13/02/2026 | Q3 2025 Earnings Release | |
| 13/02/2026 | Q3 2025 Earnings Release | |
| 13/02/2026 | Q4 2025 Earnings Release | |
| 13/02/2026 | Q4 2025 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GSK Stock
- Calendar GSK plc
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















